Aurora Cannabis Inc. Files 6-K with Financial Updates
Ticker: ACB · Form: 6-K · Filed: 2024-11-06T00:00:00.000Z
Sentiment: neutral
Topics: financial-reporting, sec-filing, cannabis
Related Tickers: ACB
TL;DR
Aurora Cannabis (ACB) dropped its Q2 2025 6-K with financials, check it out.
AI Summary
Aurora Cannabis Inc. filed a Form 6-K on November 6, 2024, for the period ending September 30, 2024. The filing includes condensed financial statements as Exhibit 99.1. Aurora Cannabis Inc. is incorporated in Alberta, Canada, and its fiscal year ends on March 31.
Why It Matters
This filing provides investors with updated financial information for Aurora Cannabis Inc., crucial for assessing the company's performance and making investment decisions.
Risk Assessment
Risk Level: medium — As a cannabis company, Aurora Cannabis operates in a highly regulated and evolving market, which presents inherent risks.
Key Numbers
- Q2 2025 — Fiscal Quarter (Period covered by the financial statements)
Key Players & Entities
- Aurora Cannabis Inc. (company) — Registrant
- 0001683541-24-000021 (other) — Accession Number
- 20240930 (date) — Period of Report
- 20241106 (date) — Filing Date
- 2833 (other) — Standard Industrial Classification Code
- 001-38691 (other) — SEC File Number
- 333-271479 (other) — Registration Statement File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is filed by Aurora Cannabis Inc. to report information that it has made or is required to make public pursuant to Canadian law, or that it has filed or will file with any stock exchange, and is submitting to the SEC, including condensed financial statements.
What period do the financial statements in this filing cover?
The financial statements in this filing cover the period of report ending September 30, 2024 (Q2 2025).
What is Aurora Cannabis Inc.'s fiscal year end?
Aurora Cannabis Inc.'s fiscal year ends on March 31.
What is Aurora Cannabis Inc.'s Standard Industrial Classification (SIC) code?
Aurora Cannabis Inc.'s SIC code is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Is this Form 6-K incorporated by reference into any other SEC filings?
Yes, this Form 6-K is incorporated by reference into the registrant's Registration Statement on Form F-10 (File No. 333-271479).
From the Filing
0001683541-24-000021.txt : 20241106 0001683541-24-000021.hdr.sgml : 20241106 20241106071320 ACCESSION NUMBER: 0001683541-24-000021 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241429225 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 form6-k20240930q22025.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F   [ ] Form 40-F  [X] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [ ] This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statement on Form F-10 (File No. 333-271479). SUBMITTED HEREWITH Exhibits Description 99.1 Condensed Consolidated Interim Financial Statements for the three and six months ended September 30, 2024 and 2023 99.2 Interim Management’s Discussion and Analysis for the three and six months ended September 30, 2024 and 2023 99.3 Certification of Chief Executive Officer 99.4 Certification of Chief Financial Officer      SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Simona King              Simona King Chief Financial Officer Date: November 6, 2024      EX-99.1 2 fs20240930q22025.htm EX-99.1 Document AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Loss and Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Condensed Consolidated Interim Statements of Cash Flows 8 Notes to the Condensed Consolidated Interim Financial Statements Note 1 Nature of Operations 9 Note 10 Share Capital 17 Note 2 Material Accounting Policies and Judgments 9 Note 11 Share-Based Compensation 18 Note 3 Biological Assets 11 Note 12 Income (Loss) Per Share 21 Note 4 Inventory 12 Note 13 Supplemental Cash Flow Information 22 Note 5 Property, Plant and Equipment 13 Note 14 Commitments and Contingencies 22 Note 6 Assets and Liabilities Held for Sale and Discontinued Operations 14 Note 15 Revenue 24 Note 7 Intangible Assets and Goodwill 15 Note 16 Segmented Information 25 Note 8 Loans and Borrowings 16 Note 17 Fair Value of Financial Instruments 27 Note 9 Lease Liabilities 17 Note 18 Financial Instruments Risk 27 AURORA CANNABIS INC. Cond